Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Fibrocell and Hefei Meifu Announce JV

publication date: Nov 5, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Fibrocell Science, Inc. will set up a joint venture with Hefei Meifu Bio-Tech Limited, centered on developing its autologous fibroblast therapies for aesthetic use in Asia, excluding Japan. Fibrocell will contribute its fibroblast IP, clinical data and manufacturing processes. Meifu will build a manufacturing facility in Hefei and be responsible for commercialization and marketing. Further financial details were not disclosed. More details....

Stock Symbol: (OTCBB: FCSC)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners